tiprankstipranks
KemPharm (KMPH)
NASDAQ:KMPH

KemPharm (KMPH) Financial Statements

0 Followers

KemPharm Financial Overview

KemPharm's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; KemPharm is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue$ 2.87M$ 1.30M$ 3.96M$ 2.58M$ 1.97M
Gross Profit$ 2.73M$ 1.25M$ 3.96M$ 2.52M$ 1.97M
EBIT$ -6.53M$ -24.72M$ -1.62M$ -2.66M$ -1.75M
EBITDA$ -6.13M$ -24.54M$ -1.55M$ -2.60M$ -1.69M
Net Income Common Stockholders$ -6.62M$ -24.04M$ -1.86M$ -2.70M$ -1.76M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 75.89M$ 80.98M$ 101.58M$ 112.35M$ 131.50M
Total Assets$ 119.55M$ 124.26M$ 125.71M$ 132.94M$ 137.19M
Total Debt$ 14.23M$ 14.35M$ 1.51M$ 1.61M$ 1.71M
Net Debt$ -61.66M$ -66.63M$ -100.07M$ -110.74M$ -129.79M
Total Liabilities$ 25.76M$ 25.02M$ 4.21M$ 5.82M$ 5.45M
Stockholders Equity$ 93.79M$ 99.23M$ 121.50M$ 127.12M$ 131.74M
Cash Flow-
Free Cash Flow$ -6.63M$ -4.19M$ -3.50M$ -865.00K$ -2.73M
Operating Cash Flow$ -6.60M$ -4.17M$ -3.48M$ -848.00K$ -2.73M
Investing Cash Flow$ 272.00K$ -33.08M$ -3.85M$ -15.44M$ -4.00K
Financing Cash Flow$ -409.00K$ 13.82M$ -4.80M$ -2.87M$ 1.94M
Currency in USD

KemPharm Earnings and Revenue History

KemPharm Debt to Assets

KemPharm Cash Flow

KemPharm Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis